Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer (Q41675935)

6 October 2017

Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer (English)

1 reference

6 October 2017

1 reference

1 reference

8

1 reference

6 October 2017

Amanda B Cooper

1

0 references

Jean-Nicolas Vauthey

15

object named as

Jean-Nicolas Vauthey

0 references

An Ngo-Huang

object named as

An Ngo-Huang

9

0 references

Jason Fleming

16

object named as

Jason B Fleming

1 reference

6 October 2017

Rebecca Slack

2

1 reference

6 October 2017

David Fogelman

3

1 reference

6 October 2017

Holly M Holmes

4

1 reference

6 October 2017

Maria Petzel

5

1 reference

6 October 2017

Nathan Parker

6

1 reference

6 October 2017

Aparna Balachandran

7

1 reference

6 October 2017

Gauri Varadhachary

10

1 reference

6 October 2017

Douglas B Evans

11

1 reference

6 October 2017

Jeffrey E Lee

12

1 reference

6 October 2017

Thomas Aloia

13

1 reference

6 October 2017

Claudius Conrad

14

1 reference

6 October 2017

Matthew H G Katz

17

1 reference

6 October 2017

18 December 2014

1 reference

Annals of Surgical Oncology

6 October 2017

1 reference

6 October 2017

22

1 reference

6 October 2017

7

1 reference

6 October 2017

2416-2423

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-014-4285-2

6 October 2017

0 references

cites work

Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Pancreaticoduodenectomy with vascular resection: margin status and survival duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

An overview of amines as nutritional supplements to counteract cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Are we closer to having drugs to treat muscle wasting disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4285-2

10.1245/S10434-014-4285-2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

6 October 2017

0 references

1 reference